BIMI International Medical (FRA:63N) COGS-to-Revenue : 0.95 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is BIMI International Medical COGS-to-Revenue?

BIMI International Medical's Cost of Goods Sold for the three months ended in Sep. 2023 was €2.26 Mil. Its Revenue for the three months ended in Sep. 2023 was €2.36 Mil.

BIMI International Medical's COGS to Revenue for the three months ended in Sep. 2023 was 0.95.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. BIMI International Medical's Gross Margin % for the three months ended in Sep. 2023 was 4.57%.

BIMI International Medical COGS-to-Revenue Historical Data

The historical data trend for BIMI International Medical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI International Medical COGS-to-Revenue Chart

BIMI International Medical Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.81

0.89

0.84

BIMI International Medical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
COGS-to-Revenue	Get a 7-Day Free Trial															0.86	0.70	0.47	0.48	0.95

BIMI International Medical COGS-to-Revenue Calculation

BIMI International Medical's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	9.327	/	11.168
	=	0.84

BIMI International Medical's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2.256	/	2.364
	=	0.95

BIMI International Medical (FRA:63N) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

BIMI International Medical's Gross Margin % for the three months ended in Sep. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	2.256 / 2.364
	=	4.57 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

BIMI International Medical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of BIMI International Medical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BIMI International Medical (FRA:63N) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (FRA:63N) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

BIMI:USA

Address

Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010

Website

https://www.usbimi.com

BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.

BIMI International Medical (FRA:63N) Headlines

No Headlines